David Hibbert Watson

AGX CEO David Hibbert Watson sells 11,873 shares for $7,837,459.46 across 2 transactions at blended $660.11 avg

David Hibbert Watson, President and CEO of ARGAN INC, executed 2 separate sales totaling 11,873 shares for $7,837,459.46, reducing his non-derivative holdings from 51,878 to 40,005 shares. The stock currently trades at $690.39, near the 52-week high of $779.00, suggesting the CEO sold into strength; however, his cross-ticker track record shows a well-timed rate of 33.33% on prior sells, indicating mixed timing performance overall. At AGX specifically, his prior 4 measurable sales showed only 1 well-timed at the 90-day mark, with 3 sales subsequently rising (poorly timed). Despite the substantial share reduction, derivative holdings of 10,578 shares remain across 3 option pools, meaning this represents a partial reduction rather than a complete position exit.

CEO Watson David Hibbert sold 19.3K shares of AGX at $602.11, reducing stake by 27.9% to 50.0K shares

Watson David Hibbert, President and CEO of Argan Inc, sold 19,310 shares at $602.11 on 2026-04-17, generating $11.6M in proceeds and reducing his holdings from 69.3K to 50.0K shares—a 27.9% reduction in his position. The sale occurred at $602.11 while the current price is $611.21 at the 52-week high, indicating the CEO executed near a significant stock peak; this comes after the stock has appreciated +29.0% over the past 30 days and +59.0% over 90 days. His same-ticker history at AGX shows mixed timing: of 5 prior sales, 2 were well-timed (90-day declines), but 3 occurred before subsequent appreciation, with the most recent sales in October 2025 capturing +12.5% and +14.4% gains in the 30-day period afterward—suggesting he has missed upside more often than not on this stock. The magnitude of this sale—nearly 28% of his prior holdings—combined with the stock near all-time highs and recent strong momentum, represents a material shift in his skin-in-the-game at a company with a P/E of 49.49 and recent quarterly net income of $30.7M.

CEO Watson Hibbert exits entire AGX stake: 5,000 shares sold for $1,382,400.34 (-100% holdings)

Watson David Hibbert, President and CEO of Argan Inc, liquidated his entire shareholding through 2 separate sales on 2025-10-09, selling 4,441 shares at $277.01 and 559 shares at $272.27, for a combined $1,382,400.34 at a blended average price of $276.48. The complete exit from a 5,000-share position is material both in scale and in signal—a CEO holding zero shares differs structurally from one with retained exposure. Across his prior open-market sales history (all tickers), Hibbert's 90-day well-timed rate stands at 50.00%, but his ticker-specific record at AGX shows 2 of 4 prior sells were well-timed at the 90-day mark. The stock currently trades at $256.15, down 9.1% from its 52-week high of $281.67 and below the blended sale price; it has risen 13.4% over 30 days and 20.7% over 90 days. Argan's fundamentals remain robust—revenue of $237.7M in the latest quarter, net income of $35.3M, annual revenue growth of +52.5%, and a market cap of $3.5B—making this a strategic position liquidation rather than a distressed sale, though the full exit raises questions about near-term conviction.

CEO Watson Hibbert sold 20,000 shares (27.7% of holdings) for $4,259,720.16 over two days in June

Watson Hibbert (PRESIDENT AND CEO) executed 2 separate sales totaling 20,000 shares for $4,259,720.16 on 2025-06-09 and 2025-06-11, reducing his holdings from 72,132 to 52,132 shares. The first sale of 2,031 shares at $230.38 preceded a second sale of 17,969 shares at $211.02, reflecting declining sale prices across the two-day period despite stock trading near 52-week highs ($243.11). His prior two sells at AGX show mixed timing outcomes: the 2024-12-18 sale delivered a +21.8% 30-day return but -19.6% at 90 days, while the 2024-07-24 sale showed -1.9% at 30 days but recovered to +60.9% at 90 days, suggesting no clear predictive pattern at this ticker. Fundamentals remain robust with FY revenue growth of +52.5%, a trailing P/E of 30.56, and recent quarterly net income of $22,550,000.00, though the current market price of $224.31 sits 7.7% below the 52-week high.

CEO Watson David Hibbert sold 10,000 shares of AGX at $146.05; stock now $139.33, down 5.1% in 30 days, up 45.3% in 90 days.

CEO Watson David Hibbert sold 10,000 shares at $146.05 on 2024-12-18, reducing his holdings by 16.4% to 50,791 shares. The stock has since declined to $139.33, down 5.1% over 30 days, despite gaining 45.3% over 90 days. Notably, his prior sale at this ticker on 2024-07-24 also resulted in a positive 90-day return (+60.9%), indicating a pattern of selling before or during periods of stock strength rather than ahead of declines. With the company generating $257.0M in quarterly revenue, $28.0M in net income, and posting +26.0% annual revenue growth at a P/E of 28.61, the CEO's discretionary reduction of a significant stake warrants observation of whether it reflects valuation concerns or other portfolio considerations.

AGX CEO David Hibbert sold 15,134 shares at $77.79, reducing stake 25.4% to 44,348 shares post-transaction.

David Hibbert, as President and CEO, executed a substantial sale of 15,134 shares totaling $1,177,273.86 on 2024-07-24. The transaction reduced his holdings from 59,482 shares to 44,348 shares—a 25.4% reduction in stake. The sale occurred at $77.79, near the stock's 52-week high of $79.58, and the stock's 90-day gain of 25.2% precedes this transaction. Argan trades at a P/E of 27.13 with strong fundamental momentum: annual revenue growth of 26.0%, latest quarter revenue of $157,682,000, and net income of $7,882,000. The material size and proportion of this sale warrant attention, particularly given the strong recent price appreciation and solid underlying earnings power, though the absence of prior transaction history at this ticker limits direct comparison.